Tianjin, China

Qinxuan Liu

This inventor holds 1 USPTO granted patent. Top assignee: Tianjin Kinsly Pharmaceutical Co. Ltd.. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qinxuan Liu: Innovator in Pharmaceutical Chemistry

Introduction

Qinxuan Liu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on adefovir dipivoxil.

Latest Patents

Qinxuan Liu holds 1 patent for his invention titled "Crystal form of adefovir dipivoxil and its preparation." This patent discloses a new crystal form of adefovir dipivoxil, specifically {9-[2-[bis(pivaloyloxy)-methoxy]-phosphinyl]-methoxyl]-ethyl]-adenine}. The invention also includes a method for preparing this crystal, which involves placing adefovir dipivoxil in a round bottom flask, adding an organic solvent, and dissolving adefovir dipivoxil ultrasonically to form a solution, followed by spray drying the solution.

Career Highlights

Qinxuan Liu is currently employed at Tianjin Kinsly Pharmaceutical Co. Ltd., where he continues to advance his research and development efforts in the pharmaceutical sector. His work has been instrumental in enhancing the understanding and application of adefovir dipivoxil in medical treatments.

Collaborations

He collaborates with talented coworkers, including Yu Tang and Liping Yang, who contribute to the innovative environment at Tianjin Kinsly Pharmaceutical Co. Ltd.

Conclusion

Qinxuan Liu's contributions to pharmaceutical chemistry, particularly through his patent on adefovir dipivoxil, highlight his role as an innovator in the field. His ongoing work at Tianjin Kinsly Pharmaceutical Co. Ltd. continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…